These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 31972500

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.
    Li X, Galliher-Beckley A, Huang H, Sun X, Shi J.
    Vaccine; 2013 Sep 23; 31(41):4508-15. PubMed ID: 23933333
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Gilt Vaccination with a Mixed Administration of a PRRS MLV and a PPV1 Subunit Vaccine Protects against Heterologous PRRSV1 Infection and Prevents Detrimental Effects on Piglet Performance.
    Garcia-Morante B, Friedrich R, Kaiser T, Kraft C, Bridger P, Noguera M.
    Viruses; 2020 Jul 23; 12(8):. PubMed ID: 32717833
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
    Charoenchanikran P, Kedkovid R, Sirisereewan C, Woonwong Y, Arunorat J, Sitthichareonchai P, Sopipan N, Jittimanee S, Kesdangsakonwut S, Thanawongnuwech R.
    Trop Anim Health Prod; 2016 Oct 23; 48(7):1351-9. PubMed ID: 27315207
    [Abstract] [Full Text] [Related]

  • 30. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
    Park C, Choi K, Jeong J, Chae C.
    Vet Microbiol; 2015 May 15; 177(1-2):87-94. PubMed ID: 25769646
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus.
    Pujhari S, Baig TT, Hansra S, Zakhartchouk AN.
    Virus Res; 2013 May 15; 173(2):321-6. PubMed ID: 23353778
    [Abstract] [Full Text] [Related]

  • 35. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W, Platt R, Johnson W, Roof M, Vaughn E, Roth JA.
    Vet Immunol Immunopathol; 2006 Jan 15; 109(1-2):99-115. PubMed ID: 16165219
    [Abstract] [Full Text] [Related]

  • 36. Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows.
    Papatsiros VG, Alexopoulos C, Kritas SK, Koptopoulos G, Nauwynck HJ, Pensaert MB, Kyriakis SC.
    J Vet Med B Infect Dis Vet Public Health; 2006 Aug 15; 53(6):266-72. PubMed ID: 16907957
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A, Li X, Bates JT, Madera R, Waters A, Nietfeld J, Henningson J, He D, Feng W, Chen R, Shi J.
    Vaccine; 2015 Jul 09; 33(30):3518-25. PubMed ID: 26049004
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.